Brazil currently stands as the fourth largest beauty and personal care market in the world. As of 2024, the Brazilian consumer landscape is characterized by a unique blend of "Biodiversity-First" ethics and an increasing demand for high-performance, science-backed formulations. At Shanghai Aeterna Biotech, we recognize that the Brazilian market is not just looking for raw materials, but for Information Gain—the synergy between global biotech efficiency and local application nuances.
Local Industrial Context: Brazil’s cosmetic industry (ABIHPEC) has shown resilient growth, driven by a population with diverse phototypes (from Type I to VI) and varying hair textures. This diversity requires raw materials that are highly versatile. The shift towards "Clean Beauty" and "Green Chemistry" in São Paulo and Rio de Janeiro manufacturing hubs has increased the demand for sustainable surfactants like Lauryl Glucoside and bio-inspired actives like Hydrolyzed Sponges.
The macro-industrial landscape is shifting from traditional botanical extracts toward Biotechnological Functional Actives. Our role as a leading manufacturer and exporter to the Brazil market involves bridging the gap between high-purity synthesis in Shanghai and the stringent regulatory environment of ANVISA (National Health Surveillance Agency).
Support for ANVISA RDC No. 752/2022 standards and Mercosur regulatory alignment for seamless importation.
Customized solubility and stability tests for raw materials tailored to the high humidity of the Brazilian tropical climate.
Strategic shipping routes from Shanghai to Santos and Paranaguá, ensuring cost-effective and timely delivery.
Globally, the cosmetic raw material sector is undergoing a transformation driven by Molecular Personalization and Zero-Carbon Supply Chains. Modern consumers demand "Efficacy Transparency." For instance, ingredients like 4-Hexylresorcinol (CAS 136-77-6) are replacing hydroquinone worldwide as the gold standard for hyperpigmentation treatment, particularly effective for Brazilian skin tones that are prone to post-inflammatory hyperpigmentation (PIH).
Our macro-industry solutions focus on three pillars:
Given Brazil's high UV index, our UV absorbers like Bemotrizinol and recovery agents like Glutathione provide dual-action protection and DNA repair for sun-stressed skin.
Brazil is the world leader in the hair care category. Our Polyisobutylene and Cocamide DEA act as vital conditioning and foaming agents for thick, curly, and treated hair textures.
The "Brazilian Glow" is achievable through our Lactobionic Acid and Ascorbyl Glucoside, providing gentle exfoliation and instant radiance suitable for salon-grade masks.
Shanghai Aeterna Biotech Co., Ltd. is a leading, reliable, and professional manufacturer specializing in fine chemicals, plant extracts, enzyme preparations, and nutritional ingredients. Our expertise spans research, development, production, and global sales. With decades of experience, we have built a solid reputation for delivering high-quality products and innovative solutions to a wide range of industries.
Our facilities are equipped with state-of-the-art production and testing equipment, allowing us to meet the highest industry standards. Through years of serving European and American markets, our QA/QC team has gained extensive experience in impurity analysis, precise control of flavor and fragrance formulations, and rigorous quality management. Our commitment to safety and reliability ensures that every product meets the expectations of both clients and end consumers.








With modern production facilities and advanced logistics, Shanghai Aeterna Biotech manufactures thousands of tons of premium products annually. Our close partnerships with major international freight forwarders in Shanghai ensure timely global distribution. We serve customers across Europe, North America, Asia, and specifically the emerging Mercosur region, offering tailored solutions that meet their specific requirements.
The future of cosmetic raw materials lies in the intersection of AI-driven molecular modeling and Synthetic Biology. Shanghai Aeterna Biotech is committed to the following technical roadmap: